NIH-funded research R01 grant

Improving tooth eruption in patients with dental disorders

Official title: Pharmacological rescue of tooth eruption disorders

Funded at University of Texas Hlth Sci Ctr Houston · NIH-10887457 · Data updated 2026-11-12

This study is looking at ways to help kids who have trouble with their teeth coming in properly, especially those with genetic conditions or issues from certain medications, by exploring new treatments that can encourage healthy tooth growth.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$462,810
NIH project number5R01DE030416-02
Project IDNIH-10887457 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include children and individuals with genetic conditions that cause tooth eruption failure or those affected by bisphosphonate-related dental issues.

Less likely to help

Patients with normal tooth eruption and no underlying dental disorders are unlikely to benefit from this research.

What this research studies

This research focuses on addressing disorders that prevent proper tooth eruption, which can significantly affect quality of life. It investigates the role of specific signaling pathways in the dental follicle that regulate tooth eruption, particularly in cases of genetic conditions and bisphosphonate-induced issues in children. The study aims to develop innovative therapies using small molecule inhibitors to enhance signaling pathways that promote tooth eruption. By understanding and manipulating these biological processes, the research seeks to provide effective treatments for patients with severe dental eruption disorders.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that restore normal tooth eruption, improving patients' ability to chew and overall quality of life.

How similar studies have gone: While the specific approach of using small molecule SIK inhibitors is novel, similar research has shown promise in enhancing signaling pathways for bone and dental health.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Ono, Wanida — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Ono, Wanida

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.